Headinvest, LLC Edwards Lifesciences Corp Transaction History

Headinvest, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 14, 2024	BUY	$72.54 - $95.56 $166,842 - $219,788	2,300 New	2,300 $219,000
Q3 2023 Dec 11, 2023	BUY	$69.28 - $93.38 $159,344 - $214,774	2,300 New	2,300 $159,000
Q3 2022 Dec 28, 2022	BUY	$82.37 - $107.29 $3,294 - $4,291	40 Added 1.6%	2,547 $210,000
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $4,894 - $6,160	-48 Reduced 1.88%	2,507 $295,000
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $4,042 - $4,965	38 Added 1.51%	2,555 $331,000
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $6,277 - $7,487	-61 Reduced 2.37%	2,517 $285,000
Q2 2021 Aug 30, 2021	BUY	$83.84 - $104.76 $8,635 - $10,790	103 Added 4.16%	2,578 $267,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $194,733 - $224,408	2,475 New	2,475 $207,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

Stay updated on Headinvest, LLC with notifications on news.